Pfizer Joining Fray in Japan AG Market with Celecox

March 17, 2020
Pfizer Japan said on March 16 that it is entering the Japanese authorized generic (AG) market with AG versions of Celecox (celecoxib) - Astellas Pharma’s non-steroid analgesic antiphlogistic being distributed by the US giant. The Celecox AGs, which obtained approval...read more